CD8A and neoplasm: Linoleic acid, identified as a primary positive regulator of CD8(+) T cell activity, enhances the anti-tumor potency of CD8(+) T cells both in vitro and in vivo and is currently being explored as an enhancer of T cell therapies in oncology [53].